M. Voulgarelis

发表

Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin

J. Ioannidis, A. Tzioufas, H. Moutsopoulos, 2000, Annals of the rheumatic diseases.

Anemia in Systemic lupus erythematosus: from pathophysiology to clinical assessment

S. Giannouli, A. Tzioufas, P. Ziakas, 2005 .

Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: A clinicopathological study

S. Giannouli, A. Tzioufas, A. Tzioufas, 2006, American journal of hematology.

Predicting Lymphoma Development by Exploiting Genetic Variants and Clinical Findings in a Machine Learning-Based Methodology With Ensemble Classifiers in a Cohort of Sjögren's Syndrome Patients

Eleni I. Georga, D. Fotiadis, T. Exarchos, 2020, IEEE Open Journal of Engineering in Medicine and Biology.

Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.

S. Giannouli, E. Zintzaras, A. Tzioufas, 2004, Rheumatology.

Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study

M. Dalakas, A. Tzioufas, H. Moutsopoulos, 2014, Journal of the Neurological Sciences.

Suspects in the tale of lupus‐associated thrombocytopenia

S. Giannouli, A. Tzioufas, P. Ziakas, 2006, Clinical and experimental immunology.

Visceral leishmaniasis resembling systemic lupus erythematosus

P. Voulgari, A. Drosos, M. Voulgarelis, 2004, Clinical rheumatology.

Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus.

J. Ioannidis, A. Tzioufas, H. Moutsopoulos, 2002, Rheumatology.

Long term remission of Sjögren’s syndrome associated aggressive B cell non-Hodgkin’s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)

S. Giannouli, A. Tzioufas, H. Moutsopoulos, 2005, Annals of the rheumatic diseases.

Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.

S. Giannouli, A. Tzioufas, M. Voulgarelis, 2004, Rheumatology.

A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion.

A. Tzioufas, P. Vlachoyiannopoulos, M. Voulgarelis, 2004, Rheumatology.

Visceral leishmaniasis resembling systemic lupus erythematosus

P. Voulgari, A. Drosos, M. Voulgarelis, 2003, Clinical Rheumatology.

Pure red cell aplasia in a Sjögren's syndrome/lupus erythematosus overlap patient

M. Voulgarelis, C. Mavragani, E. Vlachaki, 2003, American journal of hematology.

Mortality in Sjögren's syndrome.

A. Tzioufas, H. Moutsopoulos, M. Voulgarelis, 2008, Clinical and experimental rheumatology.

Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview

P. Ziakas, M. Voulgarelis, M. Voulgarelis, 2007, Journal of thrombosis and haemostasis : JTH.

Lymphoma development in a patient receiving anti-TNF therapy.

S. Giannouli, A. Tzioufas, P. Ziakas, 2003, Haematologica.

Myelodysplasia‐associated autoimmunity: clinical and pathophysiologic concepts

S. Giannouli, A. Tzioufas, A. Tzioufas, 2004, European journal of clinical investigation.

Splenic marginal zone lymphomas with peripheral CD5 expression.

S. Giannouli, G. Paterakis, P. Ziakas, 2004, Haematologica.

Autoimmune manifestations in common variable immunodeficiency

S. Giannouli, M. Voulgarelis, D. Anagnostou, 2004, Clinical Rheumatology.

Retroperitoneal fibrosis and c-ANCA positivity

M. Voulgarelis, C. Mavragani, 2005, Clinical Rheumatology.

A 47-year-old woman with persistent watery diarrhea, proteinuria, proximal weakness and monoclonal gammopathy.

M. Voulgarelis, F. Skopouli, N. Goutas, 1999, Clinical and experimental rheumatology.

Absence of somatic MYD88 L265P mutations in patients with primary Sjogren’s syndrome

S. Treon, H. Moutsopoulos, M. Voulgarelis, 2013, Genes and Immunity.

Malignant lymphoma in primary Sjogren's syndrome.

H. Moutsopoulos, M. Voulgarelis, 2001, The Israel Medical Association journal : IMAJ.

Lymphoproliferation in autoimmunity and Sjögren’s syndrome

H. Moutsopoulos, M. Voulgarelis, 2003, Current rheumatology reports.

2-chloro-2'-deoxyadenosine in the treatment of Sjögren's syndrome-associated B cell lymphoproliferation.

H. Moutsopoulos, M. Voulgarelis, F. Skopouli, 2002, Arthritis and rheumatism.

Cutaneous ulcers: An unusual manifestation of inherited thrombophilia

M. Voulgarelis, C. Mavragani, K. Aroni, 2004, American journal of hematology.

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome.

D. Isenberg, U. Dafni, H. Moutsopoulos, 1999, Arthritis and rheumatism.

Stress, coping strategies and social support in patients with primary Sjögren’s syndrome prior to disease onset: a retrospective case–control study

D. Karaiskos, A. Rabavilas, H. Moutsopoulos, 2008, Annals of the rheumatic diseases.

Acquired angioedema: a new target for rituximab?

S. Giannouli, A. Tzioufas, P. Ziakas, 2004, Haematologica.

Lupus thrombocytopenia: clinical implications and prognostic significance

S. Giannouli, E. Zintzaras, P. Ziakas, 2005, Annals of the rheumatic diseases.

Aprindine-induced hepatic granulomata.

M. Elisaf, M. Voulgarelis, E. Tsianos, 1992, Journal of hepatology.

Thrombocytopenia in lupus: baseline C3 as an independent risk factor for relapse

S. Giannouli, A. Tzioufas, P. Ziakas, 2006, Annals of the rheumatic diseases.

Membranous glomerulonephritis in chronic lymphocytic leukemia

S. Giannouli, L. Nakopoulou, P. Ziakas, 2004, American journal of hematology/oncology.

Autoimmune hemolytic anemia in patients with systemic lupus erythematosus.

J. Ioannidis, A. Tzioufas, H. Moutsopoulos, 2000, The American journal of medicine.

Anti-thrombopoietin antibodies suppress megakaryocytic colony formation in vitro in patients with systemic lupus erythaematosus

H. Papadaki, P. Ziakas, M. Voulgarelis, 2008, Annals of the rheumatic diseases.

A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.

D. Fotiadis, T. Exarchos, P. Voulgari, 2021, Journal of autoimmunity.

Thrombocytopaenia in lupus as a marker of adverse outcome--seeking Ariadne's thread.

U. Dafni, S. Giannouli, A. Tzioufas, 2006, Rheumatology.

Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al.

A. Tzioufas, H. Moutsopoulos, M. Voulgarelis, 2001, Arthritis and rheumatism.

Exacerbation of interstitial granulomatous dermatitis with arthritis by anakinra in a patient with diffuse large B-cell lymphoma.

M. Voulgarelis, D. Michailidou, D. Pikazis, 2014, Clinical and experimental rheumatology.

Clinical Phenotype and Mechanisms of Leukopenia/Neutropenia in Patients with Primary Sjögren’s Syndrome

A. Tzioufas, M. Voulgarelis, A. Goules, 2022, Mediterranean journal of rheumatology.

Patient-centered approaches for patients with systemic autoimmune rheumatic diseases: development and evolution

D. Fotiadis, P. Tsanakas, A. Tzioufas, 2022, Expert review of clinical immunology.

Monomorphic epitheliotropic intestinal T‐cell lymphoma in pleural effusion: A case report

P. Korkolopoulou, M. Voulgarelis, P. Mikou, 2017, Diagnostic cytopathology.

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome.

D. Isenberg, U. Dafni, H. Moutsopoulos, 1999, Arthritis and rheumatism.

Leukaemic synovitis.

S. Giannouli, A. Tzioufas, P. Ziakas, 2006, Rheumatology.